Browsing: Biosimilar
Zydus Lifesciences and Germany-based Formycon AG have entered into an exclusive partnership for the licensing and supply of FYB206,…
Key Takeaways: The FDA released draft guidance indicating it may approve certain biosimilars without requiring a comparative efficacy study (CES),…